C
CG Oncology Inc
NASDAQ:CGON
CG Oncology Inc
NASDAQ:CGON
Price:
51.08
USD
1.43%
Market Closed
Market Cap:
$4.1B
Income Statement
Earnings Waterfall
CG Oncology Inc
CG Oncology Inc
Income Statement
CG Oncology Inc
CG Oncology Inc
Currency: USD
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
0
N/A
|
1
+259%
|
1
+15%
|
1
-19%
|
1
+67%
|
1
-42%
|
1
-17%
|
2
+295%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(56)
|
(79)
|
(105)
|
(96)
|
(116)
|
(135)
|
(158)
|
(181)
|
|
| Selling, General & Administrative |
(10)
|
(16)
|
(23)
|
(25)
|
(34)
|
(43)
|
(53)
|
(67)
|
|
| Research & Development |
(46)
|
(63)
|
(81)
|
(71)
|
(82)
|
(92)
|
(105)
|
(113)
|
|
| Operating Income |
(55)
N/A
|
(78)
-41%
|
(104)
-33%
|
(96)
+8%
|
(115)
-20%
|
(134)
-17%
|
(157)
-17%
|
(180)
-15%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
7
|
12
|
19
|
23
|
27
|
29
|
29
|
29
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(49)
N/A
|
(66)
-35%
|
(84)
-29%
|
(72)
+14%
|
(88)
-22%
|
(106)
-20%
|
(128)
-21%
|
(151)
-18%
|
|
| Net Income | |||||||||
| Income from Continuing Operations |
(49)
|
(66)
|
(84)
|
(72)
|
(88)
|
(106)
|
(128)
|
(151)
|
|
| Net Income (Common) |
(68)
N/A
|
(85)
-25%
|
(104)
-22%
|
(78)
+24%
|
(88)
-12%
|
(106)
-20%
|
(128)
-21%
|
(151)
-18%
|
|
| EPS (Diluted) |
-1.07
N/A
|
-1.27
-19%
|
-1.55
-22%
|
-1.16
+25%
|
-1.41
-22%
|
-1.38
+2%
|
-1.68
-22%
|
-1.97
-17%
|
|
Switch to:
Switch to:
See Also
Discover More
